Summit Tx Capital, L.P. Cogent Biosciences, Inc. Put Options Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding COGT
# of Institutions
190Shares Held
111MCall Options Held
61.9KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$43.9 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$43.2 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$42.9 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$35.1 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$33.6 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $317M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...